Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Human Gene Therapy|March 27, 1999
No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cellsS E Sellers, J F Tisdale, D M Bodine, et al.
Experimental Hematology|August 1, 1993
Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myeloproliferative syndrome but is associated with circulating interleukin-3 levelsP J Orchard, R A Detrick, K Gorden, et al.
Bone Marrow Transplantation|April 16, 1998
T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopeniaD A Mavroudis, E J Read, J Molldrem, et al.
Bone Marrow Transplantation|January 10, 2006
A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosisR Nakamura, S Chakrabarti, C Akin, et al.
Bone Marrow Transplantation|May 7, 2003
Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantationS R Solomon, R Nakamura, E J Read, et al.
Blood|August 1, 1996
Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase--deficient severe combined immunodeficiency disease patientsS Sekhsaria, T A Fleisher, S Vowells, et al.
British Journal of Haematology|January 29, 2000
Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemiaN Giri, E Kang, J F Tisdale, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factorC E Dunbar, N E Seidel, S Doren, et al.
Gene Therapy|July 26, 2002
In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate modelY Hanazono, T Nagashima, M Takatoku, et al.
Pageof 8